Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3 Business Technology Group Regulatory News (KBT)

  • There is currently no data for KBT

Correction - Director/PDMR Sh

1 Aug 2008 11:43

RNS Number : 4583A
K3 Business Technology Group PLC
01 August 2008
 

K3 Business Technology Group plc ("K3" or the "Company")

Director dealing - correction

This announcement corrects the announcement made on 5 June 2008, RNS Number : 0434W, in which Mr Johan Claesson's holding in the Company was incorrectly disclosed. The correct text appears below.

K3 announces that the Subscription Period for Warrants issued pursuant to a Warrant Instrument dated 23 June 2005 entitling Johan Och Marianne Claesson AB, a Swedish company associated with Mr Johan Claesson (a non-executive director of the Company) to subscribe for 400,000 ordinary shares in the capital of the Company at a price per share of 90 pence has today been extended from 22 June 2008 to expire on 31 December 2008. All other terms of the Warrants remain unaltered.

The extension to the Subscription Period has been made in recognition of the continuing variation of loan repayment terms by CA Fastigheter AB, a company associated with Mr Claesson 

Mr Claesson holds 4,001,448 ordinary shares of 25 pence each in the capital of the Company. - ENDS -

 

 

For further information:

K3 Business Technology Group plc:

David Bolton, Chief Finance Officer +44 (0) 1282 864 111

Daniel Stewart & Company Plc

Paul Shackleton +44 (0) 20 7776 6550

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUUUMWRUPRGUG
Date   Source Headline
19th Jun 20237:00 amRNSPDMR Announcement
30th May 20231:30 pmRNSPDMR Announcement
23rd May 202311:15 amRNSResult of AGM
19th May 20235:52 pmRNSHolding(s) in Company
19th May 20235:45 pmRNSPDMR Announcement
19th May 20232:45 pmRNSHolding(s) in Company
18th May 202312:58 pmRNSHolding(s) in Company
18th May 202312:45 pmRNSHolding(s) in Company
18th May 202312:40 pmRNSPDMR Announcement
9th May 20237:28 amRNSPDMR Announcement
2nd May 20239:35 amRNSPDMR Announcement
2nd May 20239:35 amRNSPDMR Announcement
28th Apr 20234:07 pmRNSPosting of Annual Report and Notice of AGM
12th Apr 202312:57 pmRNSDirector/PDMR Shareholding
3rd Apr 20231:30 pmRNSPDMR Announcement
30th Mar 20237:00 amRNSFinal Results
30th Mar 20237:00 amRNSBoard Appointment
7th Mar 20237:00 amRNSLargest Order Win for Flagship Fashion Product
6th Feb 202310:00 amRNSPDMR Announcement
23rd Jan 202311:10 amRNSPDMR Announcement
12th Jan 20237:00 amRNSTrading Update
28th Nov 20225:07 pmRNSHolding(s) in Company
28th Nov 20225:05 pmRNSPDMR Announcement
21st Nov 20225:40 pmRNSPDMR Announcement
14th Nov 202212:50 pmRNSPDMR Announcement
7th Nov 20223:53 pmRNSPDMR Announcement
17th Oct 202210:46 amRNSPDMR Announcement
17th Oct 202210:46 amRNSPDMR Announcement
20th Sep 20224:45 pmRNSPDMR Announcement
12th Sep 20225:31 pmRNSPDMR Announcement
24th Aug 20227:00 amRNSInterim Results
26th Jul 20227:00 amRNSBoard Appointment
19th May 202210:57 amRNSResult of AGM
18th May 20225:27 pmRNSK3 LTIP Option Scheme
16th May 202210:42 amRNSPDMR Announcement
9th May 202212:47 pmRNSPDMR Announcement
3rd May 20223:07 pmRNSPDMR Announcement
22nd Apr 20227:00 amRNSNotice of AGM and Posting of Annual Report
12th Apr 20227:00 amRNSDirector/PDMR Shareholding
5th Apr 20227:00 amRNSBoard Retirement
5th Apr 20227:00 amRNSFinal Results
28th Feb 202212:06 pmRNSPDMR Announcement
14th Feb 20222:43 pmRNSPDMR Announcement
9th Feb 20223:00 pmRNSShare Option Scheme
7th Feb 20224:45 pmRNSHolding(s) in Company
7th Feb 20224:43 pmRNSPDMR Announcement
1st Feb 20229:03 amRNSPDMR Announcement
27th Jan 202212:50 pmRNSStrategic Acquisition of IP
23rd Dec 20215:05 pmRNSHolding(s) in Company
22nd Dec 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.